Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver
- PMID: 2924904
- DOI: 10.1016/0014-5793(89)81193-7
Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver
Abstract
Acetyl CoA-dependent arylamine N-acetyltransferase (EC 2.3.1.5) is the target of a genetic polymorphism in the metabolism of drugs and carcinogens. N-Acetyltransferase was purified 1000-fold from cytosol of human liver and its identity was verified by amino acid sequence homology of two of its tryptic peptides with published rabbit and chicken N-acetyltransferase sequences. Enzyme activity correlated with the presence of two proteins, NAT-1 and NAT-2, with indistinguishable molecular masses (31 kDa). NAT-1 and NAT-2 could be separated by anion-exchange chromatography and were functionally distinguished by their different apparent affinities for the acceptor amine sulfamethazine (SMZ). Antibodies raised against NAT-1 were able to recognize both isozymes on Western blots.
Similar articles
-
Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.Mol Pharmacol. 1991 Feb;39(2):184-91. Mol Pharmacol. 1991. PMID: 1996083
-
Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.Cancer Res. 1990 Dec 15;50(24):7942-9. Cancer Res. 1990. PMID: 2253236
-
Purification and partial characterization of chicken liver acetyl coenzyme A: arylamine N-acetyltransferase.Comp Biochem Physiol B. 1987;86(3):601-6. doi: 10.1016/0305-0491(87)90455-x. Comp Biochem Physiol B. 1987. PMID: 3595092
-
Arylamine N-acetyltransferases: from structure to function.Drug Metab Rev. 2008;40(3):479-510. doi: 10.1080/03602530802186603. Drug Metab Rev. 2008. PMID: 18642144 Review.
-
Arylamine N-acetyltransferases - of mice, men and microorganisms.Trends Pharmacol Sci. 2001 Mar;22(3):140-6. doi: 10.1016/s0165-6147(00)01639-4. Trends Pharmacol Sci. 2001. PMID: 11239577 Review.
Cited by
-
N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.Gut. 1997 Aug;41(2):229-34. doi: 10.1136/gut.41.2.229. Gut. 1997. PMID: 9301503 Free PMC article.
-
Detoxification pathways in the liver.J Inherit Metab Dis. 1991;14(4):421-30. doi: 10.1007/BF01797915. J Inherit Metab Dis. 1991. PMID: 1749210 Review.
-
Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.Biochem J. 2000 May 15;348 Pt 1(Pt 1):159-66. Biochem J. 2000. PMID: 10794727 Free PMC article.
-
Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.J Clin Invest. 1990 Mar;85(3):968-72. doi: 10.1172/JCI114527. J Clin Invest. 1990. PMID: 2312737 Free PMC article.
-
Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.Rheumatol Int. 1995;14(6):257-60. doi: 10.1007/BF00262093. Rheumatol Int. 1995. PMID: 7597382
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases